Literature DB >> 24090918

Indenoindoles and cyclopentacarbazoles as bioactive compounds: synthesis and biological applications.

Pal Rongved1, Gilbert Kirsch, Zouhair Bouaziz, Joachim Jose, Marc Le Borgne.   

Abstract

Indenoindoles and their isomers cyclopentacarbazoles represent a wide class of synthetic and natural compounds. The great interest of these structures in (bio)organic chemistry is due to the use of various building blocks to get the elemental four ring structure. Depending on the synthetic route chosen, the chemists can achieve a large number of regioisomers. Each regioisomer can be considered as a template for specific functionalizations. Therefore, this mini-review aims (i) to present an overview on how to access this large family of heterocyclic compounds and (ii) to discuss their various biological applications and drug development in oncology (e.g. kinases), in CNS disorders (e.g. Alzheimer's disease), in endocrinology (e.g. hormone replacement therapy) and oxidative stress (e.g. organ preservation). Past and present works will be presented through the systems 6-5-5-6 and 6-5-6-5 (combination of 6-membered and 5-membered rings).
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Biological applications; CNS disorders; Cancer; Cardiovascular diseases; Chemical syntheses; Cyclopentacarbazoles; Diabetes; Indenoindoles; Oxidative stress

Mesh:

Substances:

Year:  2013        PMID: 24090918     DOI: 10.1016/j.ejmech.2013.08.049

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2.

Authors:  Faten Alchab; Laurent Ettouati; Zouhair Bouaziz; Andre Bollacke; Jean-Guy Delcros; Christoph G W Gertzen; Holger Gohlke; Noël Pinaud; Mathieu Marchivie; Jean Guillon; Bernard Fenet; Joachim Jose; Marc Le Borgne
Journal:  Pharmaceuticals (Basel)       Date:  2015-06-08

2.  Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.

Authors:  Jennifer Hochscherf; Dirk Lindenblatt; Benedict Witulski; Robin Birus; Dagmar Aichele; Christelle Marminon; Zouhair Bouaziz; Marc Le Borgne; Joachim Jose; Karsten Niefind
Journal:  Pharmaceuticals (Basel)       Date:  2017-12-13

3.  Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining.

Authors:  Samer Haidar; Zouhair Bouaziz; Christelle Marminon; Tuomo Laitinen; Antti Poso; Marc Le Borgne; Joachim Jose
Journal:  Pharmaceuticals (Basel)       Date:  2017-01-09

4.  Broad-Spectrum Anticancer Activity and Pharmacokinetic Properties of a Prenyloxy-Substituted Indeno[1,2-b]indole Derivative, Discovered as CK2 Inhibitor.

Authors:  Ehab El-Awaad; Robin Birus; Christelle Marminon; Zouhair Bouaziz; Laurens Ballentin; Dagmar Aichele; Marc Le Borgne; Joachim Jose
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-05

5.  QSAR Model of Indeno[1,2-b]indole Derivatives and Identification of N-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-b]furan-3-carboxamide as a Potent CK2 Inhibitor.

Authors:  Samer Haidar; Christelle Marminon; Dagmar Aichele; Abdelhamid Nacereddine; Wael Zeinyeh; Abdeslem Bouzina; Malika Berredjem; Laurent Ettouati; Zouhair Bouaziz; Marc Le Borgne; Joachim Jose
Journal:  Molecules       Date:  2019-12-26       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.